Ping Wang, PhD, D(ABCC), FADLM is currently Chief of Clinical Chemistry and Director of Core Laboratory at Hospital of University of Pennsylvania (HUP), and Associate Professor of Pathology and Laboratory Medicine at University of Pennsylvania. She completed a Clinical Chemistry Fellowship at the University of California, San Francisco, and is board certified in Clinical Chemistry, Molecular Diagnostics, and Toxicological Chemistry. In her clinical role, she oversees the clinical operation of a 10-million tests/year core lab and 3-million tests/year point-of-care testing. In her research role, Dr. Wang conducts research aiming to improve precision-based disease diagnosis and prognosis by developing next-generation central laboratory methods and point of care devices with novel sensors, materials and microfluidics. She is Principle Investigator on many NIH and industry funded projects, and holds patents and published extensively on these topics. Dr. Wang provides leadership in laboratory medicine and clinical chemistry, serves on the FDA Medical Devices Advisory Committee, and leads research focused on translating innovative diagnostic technologies into clinical care. She also holds active leadership and advisory roles in more than 10 professional organizations and committees.